XML 31 R19.htm IDEA: XBRL DOCUMENT v3.10.0.1
STOCKHOLDERS' EQUITY
12 Months Ended
Dec. 31, 2018
Stockholders' Equity Note [Abstract]  
Stockholders' Equity Note Disclosure [Text Block]

NOTE 12.   STOCKHOLDERS’ EQUITY


Share-based compensation


Share-based compensation expense consisted of the following:


 

 

Year ended December 31,

 

 

2018

 

2017

Employee Awards

$

3,626,271

$

3,742,294

Consulting Awards

 

306,466

 

34,399

Feinsod Agreement

 

2,062,270

 

104,134

 

$

5,995,007

$

3,880,827


Employee Stock Options


On October 29, 2014, the Board authorized the adoption of and, on June 26, 2015, our stockholders ratified, our 2014 Equity Incentive Plan for the issuance of 10 million shares of our common stock and, in April 2018, stockholders approved an increase of 5 million shares of common stock that may be granted (the “Incentive Plan”). The Incentive Plan provides for the issuance of up to 15 million shares of our common stock and is designed to provide an additional incentive to executives, employees, directors and key consultants, aligning our long term interests with participants. A Registration Statement on Form S-8 for the initial 10 million shares automatically became effective in May 2016, and a Registration Statement on Form S-8 for the additional 5 million shares and 900,000 shares under the Feinsod Agreement automatically became effective in June 2018 (collectively, the “Registration Statements”). The Registration Statements relate to 15,000,000 shares of our common stock, which are issuable pursuant to or, upon exercise of, options that have been granted or may be granted under our Incentive Plan. As of December 31, 2018, there were 13,147,214 shares available to issue under the Incentive Plan.


Share-based compensation costs for award grants to employees and directors (“Employee Awards”) are recognized on a straight-line basis over the service period for the entire award, with the amount of compensation cost recognized at any date equaling at least the portion of the award that is vested.  The following summarizes the Black-Scholes assumptions used for Employee Awards granted:


 

 

Year ended December 31,

 

 

2018

 

2017

Exercise price

 

$1.71 – 7.17

 

$1.34 – 4.23

Stock price on date of grant

 

$1.71 – 7.17

 

$1.34 – 4.23

Volatility

 

131 – 140%

 

140 – 153%

Risk-free interest rate

 

2.1 – 2.9%

 

1.4 – 2.3%

Expected life (years)

 

3.0

 

3.0 – 5.0

Dividend yield

 

 


The following summarizes Employee Awards activity:


 

 

Number of Shares

 

Weighted-average Exercise Price per Share

 

Weighted-average Remaining Contractual Term

(in years)

 

Aggregate Intrinsic Value

Outstanding at December 31, 2016

 

8,818,400

$

1.04

 

 

 

 

Granted

 

1,496,100

 

2.29

 

 

 

 

Exercised

 

(1,012,522)

 

0.78

 

 

 

 

Forfeited or expired

 

(596,700)

 

1.19

 

 

 

 

Outstanding at December 31, 2017

 

8,705,278

 

1.28

 

 

 

 

Granted

 

2,160,525

 

3.41

 

 

 

 

Exercised

 

(731,264)

 

0.99

 

 

 

 

Forfeited or expired

 

(961,159)

 

2.47

 

 

 

 

Outstanding at December 31, 2018

 

9,173,380

 

1.68

 

6.0

$

3,934,000

 

 

 

 

 

 

 

 

 

Exercisable at December 31, 2018

 

7,133,905

$

1.18

 

6.7

$

3,934,000


Based on our estimated forfeiture rates, we expect 2,023,563 Employee Awards will vest.  As of December 31, 2018, there was approximately $3,281,291 of total unrecognized compensation expense related to unvested Employee Awards, which is expected to be recognized over a weighted-average period of ten months.


Consulting Services


As needed, we may issue warrants to third parties in exchange for consulting services.  Stock-based compensation costs for award grants to third parties for consulting services (“Consulting Awards”) are recognized on a straight-line basis over the service period for the entire award, with the amount of compensation cost recognized at any date equaling at least the portion of the award that is vested.  Service Awards are revalued at each reporting date until fully vested, which may generate an expense or benefit.


The fair value of each warrant grant is estimated using Black-Scholes.  We use historical data to estimate the expected price volatility.  The risk-free interest rate is based on the United States Treasury yield curve in effect at the time of valuation for the estimated life of the option.  The following summarizes the Black-Scholes assumptions used for Consulting Awards granted:


 

 

Year ended December 31,

 

 

2018

 

2017

Exercise price

$

3.08

$

1.40

Stock price, date of valuation

$

3.08

$

1.40

Volatility

 

134%

 

128%

Risk-free interest rate

 

2.3%

 

1.7%

Expected life (years)

 

2.0

 

2.0

Dividend yield

 

 


The following summarizes Consulting Awards activity:


 

 

Number of Shares

 

Weighted-average Exercise Price per Share

 

Weighted-average Remaining Contractual Term

(in years)

 

Aggregate Intrinsic Value

Outstanding at December 31, 2016

 

157,500

$

1.96

 

 

 

 

Granted

 

10,000

 

1.40

 

 

 

 

Forfeited or expired

 

(40,000)

 

3.62

 

 

 

 

Outstanding at December 31, 2017

 

127,500

 

2.40

 

 

 

 

Granted

 

35,000

 

3.08

 

 

 

 

Exercised

 

(75,000)

 

1.31

 

 

 

 

Forfeited or expired

 

(37,500)

 

1.66

 

 

 

 

Outstanding and exercisable at
December 31, 2018

 

50,000

 

2.53

 

1.3

$

4,000


We granted 25,000 shares of common stock with a fair value of $92,500 to a non-employee for consulting services, which were issued in July 2018.  Additionally, we granted 47,933 shares of common stock with a fair value of $142,500 to non-employees for consulting services, which were issued in October 2018.


Feinsod Employment Agreement


On December 8, 2017, we entered into an agreement (the “Feinsod Agreement”) with Michael Feinsod for his continued service as our Executive Chairman of our Board of Directors. Pursuant to the agreement, Mr. Feinsod received (a) 600,000 stock options that vest on the anniversary date of the agreement for the next three years, or 200,000 per year (“Time-based Options”); and (b) three tranches of 100,000 stock options that vest when our stock price has an average trading price for 20 days of $3.50, $5.00 and $6.50 (“Market-based Options”). The options have an exercise price of $3.45 per share and a ten-year life. These options were not issued under the Incentive Plan; however, the underlying shares were included in the Registration Statement on Form S-8 that automatically became effective in June 2018. During the quarter ended March 31, 2018, the $3.50 and $5.00 Market-based Options vested and, accordingly, the expense associated with those options was recognized immediately.


DB Option Agreement warrants


In order to extend the DB Option Agreement with Infinity Capital, in March 2016 we granted Infinity Capital warrants to purchase 100,000 shares of our common stock at an exercise price of $0.67 per share with a five year life.  All 100,000 warrants were still outstanding as of December 31, 2018.


IPG Acquisition Warrants


In connection with the IPG acquisition in 2015, we issued to IPG 500,000 fully-vested warrants to purchase a) 250,000 shares of our common stock at $4.50 per share, (the “IPG $4.50 Warrants”), and b) 250,000 shares of our common stock at $5.00 per share (the “IPG $5.00 Warrants”) (collectively, the “IPG Warrants”). All of these warrants expired unexercised during the quarter ended March 31, 2018.


Warrants with Debt


The following summarizes warrants issued with debt activity:


 

 

Number of Shares

 

Weighted-average Exercise Price per Share

 

Weighted-average Remaining Contractual Term

(in years)

 

Aggregate Intrinsic Value

Outstanding at December 31, 2016

 

9,025,843

$

0.63

 

 

 

 

Granted

 

(5,633,517)

 

0.61

 

 

 

 

Cancelled

 

(40,626)

 

1.16

 

 

 

 

Outstanding at December 31, 2017

 

3,351,700

 

0.65

 

 

 

 

Granted

 

6,000,000

 

2.35

 

 

 

 

Exercised

 

(3,316,786)

 

0.77

 

 

 

 

Expired

 

(42,700)

 

5.00

 

 

 

 

Outstanding and exercisable at
December 31, 2018

 

5,992,214

 

2.26

 

1.3

$

186,620


Fall 2017 Capital Raise


During the year ended December 31, 2017, in a private placement we raised $4 million of equity by issuing four million shares of our common stock and four million warrants (“Fall 2017 Warrants”) to purchase shares of our common stock (together “Units”) for $1.00 per Unit.  The Fall 2017 Warrants had an exercise price of $0.50 per share and were exercisable for two years.  If our common stock closed above $5.00 for ten consecutive days, we could call the warrants, giving the warrant holders 10 days to exercise.  During the quarter ended March 31, 2018, we called the warrants and all were exercised.  In consideration for the sale of the Units, we received $3,750,000 in cash and extinguished $250,000 of 12% Notes.